
Granichem 1mg Injection
Marketer
Swastik Life Sciences
Salt Composition
Granisetron (1mg)
Overview Granichem 1mg Injection
Onxeme 1mg Injection, an antiemetic medication, effectively manages nausea and vomiting resulting from surgery, chemotherapy, or radiation. Onxeme 1mg Injection does not alleviate other cancer treatment side effects. Administered by a healthcare provider, its use should strictly follow medical guidance. Continued injections are crucial until medically discontinued, potentially transitioning to oral medication thereafter. Common side effects—injection site discomfort, headache, bowel irregularities (constipation or diarrhea), and fatigue—typically resolve upon cessation. However, persistent or troublesome symptoms warrant discussion with your doctor, who can offer management strategies. Prior to use, disclose any heart, liver, or gastrointestinal obstruction issues, and list all current medications, especially those for epilepsy, heart conditions, cancer, or depression, as interactions may occur. Pregnant or breastfeeding individuals should consult their healthcare team before use.
Uses of Granichem 1mg Injection
Chemotherapy-induced emesis
Major Benefits of Granichem 1mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Granichem 1mg Injection:
- Injection site pain
- Constipation
- Diarrhea
- Headache
- Weakness
- Insomnia (difficulty in sleeping)
How to use Granichem 1mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
How Granichem 1mg Injection works:
Granichem 1mg Injection is an anti-vomiting drug. Its mechanism involves the inhibition of serotonin, a neurotransmitter in the brain that triggers nausea and vomiting, often associated with cancer therapy (chemotherapy) or post-operative recovery.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Granichem 1mg Injection may pose safety risks; seek medical advice before combining them.
PregnancySAFE IF PRESCRIBED
The injectable medication Granichem, at a 1mg dose, is typically deemed safe for use during gestation. Preclinical trials in animals revealed minimal or no harmful consequences for fetal development; nonetheless, research involving human subjects is scarce.
Breast feedingSAFE IF PRESCRIBED
Administration of Granichem 1mg Injection while breastfeeding is likely safe. Available human data indicates minimal risk to the infant.
DrivingSAFE
Driving ability is typically unaffected by Granichem 1mg Injection.
KidneySAFE IF PRESCRIBED
Granichem 1mg Injection is likely safe for individuals with impaired kidney function. Current evidence indicates dose modification may be unnecessary; however, medical advice is recommended.
LiverSAFE IF PRESCRIBED
Granichem 1mg Injection is likely safe for individuals with hepatic impairment. Current evidence indicates dose modification may be unnecessary in such cases. Physician consultation is advised.
What if you forget to take Granichem 1mg Injection :
Should you forget a dose of Granichem 1mg Injection, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Granichem 1mg Injection
| Label | Value |
|---|---|
| Chemical Type | Indazole compound |
| Developing Habits | No. |
| Treatment Category | Gastrointestinal system |
| Actions | 5-HT3 receptor blockers |
